Traditional trial start-up workflows often follow a sequential path, from feasibility to contracting, then regulatory ...

World-leading challenge study expertise helping deliver scalable, high-quality outpatient vaccine trials in healthy ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

One-year follow-up data from Phase 2 trial of once-weekly canvuparatide, a potential best-in-class therapy for ...

Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...

At week 12, the highest dosed patients achieved the best tissue response seen in the trial to date, with a near complete ...

Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...

CK0804, a regulatory T cell therapy, received FDA orphan drug designation for myelofibrosis, supporting rare disease treatment development. Clinical study results showed significant reductions in ...

ASPIRO is the first multi-patient, multi-center clinical trial of an autologous cell therapy for Parkinson's disease. It is evaluating safety, tolerability, and preliminary efficacy of ANPD001 in ...

HOK has submitted plans to Westminster City Council for a 48,800m2 clinical life sciences hub at St Mary’s Hospital, close to ...

As someone who finds the field of science fascinating, I often consider the roles that human and veterinary medicine play in advancing science, particularly through cardiac surgical programs. With ...